Arunjyoti Bio Ventures Ltd Valuation
ABVL · Financial Services · Current price ₹4.78
Is Arunjyoti Bio Ventures Ltd undervalued?
DocStoX estimates the fair value of Arunjyoti Bio Ventures Ltd at ₹6 per share, versus the current market price of ₹5. That puts the stock about +17.9% below our fair-value estimate, which we read as "Fairly Valued". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 2 independent methods: Excess-return (book value) (₹1), Relative P/E (₹18). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹1 (bear) to ₹6 (base) to ₹18 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Valuation multiples
Arunjyoti Bio Ventures Ltd trades at a P/E of — and a P/B of 3.2x, with a dividend yield of 0.0%. Multiples are most useful compared against the company's own history and its sector peers — see the peer comparison for context.
Understand the ratios
More on Arunjyoti Bio Ventures Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.